Cart
sales@molnova.com
JNJ-7706621
CAS No. 443797-96-4
JNJ-7706621( JNJ7706621 | JNJ 7706621 )
Catalog No. M14517 CAS No. 443797-96-4
A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 55 | In Stock |
|
| 5MG | 96 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 268 | In Stock |
|
| 50MG | 492 | In Stock |
|
| 100MG | 690 | In Stock |
|
| 500MG | 1395 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-7706621
-
NoteResearch use only, not for human use.
-
Brief DescriptionA dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM).
-
DescriptionA dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM), and no activity for Plk1 or Wee1; arrests the cell cycle at the G2-M phase; shows significant antitumor activity in tumor xenograft model.
-
In Vitro——
-
In Vivo——
-
SynonymsJNJ7706621 | JNJ 7706621
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorAuroraA|AuroraB|CDK1/CyclinB|CDK2/CyclinA|CDK2/CyclinE
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number443797-96-4
-
Formula Weight394.356
-
Molecular FormulaC15H12F2N6O3S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=S(C1=CC=C(NC2=NN(C(C3=C(F)C=CC=C3F)=O)C(N)=N2)C=C1)(N)=O
-
Chemical NameBenzenesulfonamide, 4-[[5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Emanuel S, et al. Cancer Res. 2005 Oct 1;65(19):9038-46.
2. Huang S, et al. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3639-41.
3. Seamon JA, et al. Mol Cancer Ther. 2006 Oct;5(10):2459-67.
molnova catalog
related products
-
LY2857785
LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
-
TBB
TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).
-
Tricin
Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9.?Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.
